Mycobacterium gordonae: a treatable disease in HIV-positive patients

Chest. 1993 Dec;104(6):1779-85. doi: 10.1378/chest.104.6.1779.

Abstract

Purpose: To evaluate the pathogenicity of Mycobacterium gordonae in patients with and without human immunodeficiency virus (HIV) infection.

Patients and methods: Twenty-one HIV-positive and 15 HIV-negative patients in a tertiary care center. A descriptive, case-control, and cohort study with a review of the literature with a computer-based data research.

Results: The 15 HIV-negative patients had colonization only. Seven HIV-positive patients had colonization, 12 had possible disease, and 2 had dissemination. The two patients with definitive dissemination improved objectively with treatment.

Conclusion: Mycobacterium gordonae in HIV-negative patients is rarely a pathogen. In HIV-positive patients with a low CD4+ cell count, it can cause significant disease and treatment is beneficial.

MeSH terms

  • AIDS-Related Opportunistic Infections / diagnosis
  • AIDS-Related Opportunistic Infections / therapy*
  • Adult
  • Case-Control Studies
  • Female
  • HIV Seronegativity
  • HIV Seropositivity / complications*
  • Humans
  • Male
  • Middle Aged
  • Mycobacterium Infections, Nontuberculous / diagnosis
  • Mycobacterium Infections, Nontuberculous / therapy*
  • Retrospective Studies
  • Tuberculosis, Pulmonary / diagnosis
  • Tuberculosis, Pulmonary / therapy*